Unlabelled: The molecular force of blood-stage infection (FOB) is a quantitative surrogate metric for malaria transmission at population level and for exposure at individual level. Relationships between FOB, parasite prevalence and clinical incidence were assessed in a treatment-to-reinfection cohort, where () hypnozoites were eliminated in half the children by primaquine (PQ). Discounting relapses, children acquired equal numbers of new () and blood-stage infections/year (FOB = 0-18, FOB = 0-23) resulting in comparable spatial and temporal patterns in incidence and prevalence of infections. Including relapses, FOB increased >3 fold (relative to PQ-treated children) showing greater heterogeneity at individual (FOB = 0-36) and village levels. and FOB were strongly associated with clinical episode risk. Yearly clinical incidence rate (IR = 0.28) was higher than for (IR = 0.12) despite lower FOB. These relationships between FOB, clinical incidence and parasite prevalence reveal a comparable decline in and transmission that is normally hidden by the high burden of relapses.
Clinical Trial Registration: ClinicalTrials.gov NCT02143934.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606846 | PMC |
http://dx.doi.org/10.7554/eLife.23708 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!